industry
23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction ...
reut.rs/3W4d3nD
The Next Frontier for Brain Implants Is Artificial Vision: Elon Musk’s Neuralink and others are developing devices that could provide blind people with a crude ...
wired.com/story/the-next-frontier-for-brain-implants-is-artificial-vision-neuralink-elon-musk/
Quick Glance: Artificial Vision Through Brain Implants
- Brian Bussard has 25 tiny brain chips providing him with rudimentary vision.
- Research from Neuralink and other companies aims to enable artificial vision for blind individuals through brain implants.
- The technology bypasses the eye and optic nerve to enhance vision, regardless of the cause of blindness.
- Focus lies on enhancing image quality and customizing implants for optimal performance.
AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition: AstraZeneca shareholders on Thursday approved a 2024 pay policy which will boost ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-shareholders-approve-2024-pay-policy-boost-ceo-soriot-2024-04-11/
Vertex Pharma boosts immunotherapy business in $4.9 bln Alpine Immune deal: Vertex Pharmaceuticals will buy Alpine Immune Sciences for about $4.9 billion in cash ...
reuters.com/markets/deals/vertex-pharmaceuticals-buy-alpine-immune-sciences-49-bln-2024-04-10/
Lawsuit for damages: Astrazeneca must provide all coronavirus vaccination data: After the coronavirus vaccination, a 33-year-old woman suffers a thrombosis ...
n-tv.de/panorama/Astrazeneca-muss-alle-Corona-Impfdaten-vorlegen-article24858639.html
Quick Glance: Lawsuit after severe illness from Corona vaccination against Astrazeneca
- A woman from Upper Franconia achieves partial success against Astrazeneca in the lawsuit over serious health consequences after a Corona vaccination.
- Astrazeneca must provide comprehensive information on side effects of its vaccine.
- Plaintiff demands compensation and damages after severe illness from vaccination.
- Further lawsuits against Corona vaccine manufacturers may follow, while the woman's lawsuit continues.
Over 160% Price Chance: Cathie Wood Can't Stop Buying These Stocks: Cathie Wood massively buys Intellia and PacBio shares, sees 160% potential despite current ...
boerse-online.de/nachrichten/aktien/ueber-160-kurschance-cathie-wood-kann-nicht-aufhoeren-diese-aktien-zu-kaufen-20355055.html
Moderna pauses Kenya plant plans as COVID vaccine demand wanes: Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in ...
reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/
Exclusive: Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial
reuters.com/business/healthcare-pharmaceuticals/synchron-rival-musks-neuralink-readies-large-scale-brain-implant-trial-2024-04-08/
EU approves Illumina's plan to divest cancer test maker Grail: U.S. gene sequencing company Illumina's plan to divest cancer diagnostic test maker Grail received ...
reuters.com/business/healthcare-pharmaceuticals/eu-approves-illuminas-plan-divest-cancer-test-maker-grail-2024-04-12/
Pfizer wins pause on Moderna's COVID-19 patent lawsuit: Moderna's patent lawsuit claiming Pfizer and BioNTech copied its COVID-19 vaccine technology will be put ...
reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed
reuters.com/business/healthcare-pharmaceuticals/illumina-cfo-goswami-depart-summit-therapeutics-dhingra-named-successor-2024-04-09/
Influenza and coronavirus: one step closer to a combined vaccine: Moderna has been working for some time on the possibility of developing a vaccine that is ...
diepresse.com/18326862/influenza-und-corona-virus-einem-kombinierten-impfstoff-ein-stueck-naeher
Quick Glance: Advances in Combined Influenza and Covid-19 Vaccine
- Moderna progresses in developing a combined vaccine for Influenza and Covid-19.
- New Sars-CoV-2 vaccine elicits stronger immune response than current one.
- Study shows enhanced immune response in individuals over 65 years.
- Focus on targeted antibodies and extended vaccine shelf life in development.
AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial: AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival ...
reuters.com/business/healthcare-pharmaceuticals/astrazenecas-imfinzi-shows-promise-treating-aggressive-lung-cancer-2024-04-05/
Quick Glance: AstraZeneca's Imfinzi Shows Promise in Treating Aggressive Lung Cancer
- AstraZeneca announced that their cancer drug Imfinzi helps improve overall and progression-free survival in patients with limited-stage small cell lung cancer.
- In a late-stage trial, the drug demonstrated a statistically significant and clinically meaningful improvement in the dual primary goals of overall survival and progression-free survival.
- Small cell lung cancer is recognized for its high level of aggressiveness and rapid disease progression despite initial treatment with chemotherapy and radiotherapy.
- Imfinzi is part of the Anglo-Swedish drugmaker's key cancer portfolio and accounted for 23% of total group revenue last year.
Moderna jumps as vaccine shows benefit in head and neck cancer in early study: Moderna shares rose 8% to a three-month high on Tuesday after the company's ...
reuters.com/markets/us/moderna-jumps-personalized-cancer-vaccine-shows-benefit-early-study-2024-04-09/
Novartis begins tender offer for cancer-focused MorphoSys: Novartis said on Thursday it has launched a tender offer to acquire MorphoSys ...
reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials
qz.com/norvartis-morphosys-deal-cancer-trials-pause-1851403095
Moderna shares fall after judge sides with Arbutus in patent fight: Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order that strengthened ...
reuters.com/legal/moderna-shares-fall-after-judge-sides-with-arbutus-patent-fight-2024-04-03/
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors: The U.S. Food and Drug Administration on Friday gave accelerated approval for the ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-daiichi-astrazeneca-drug-treatment-solid-tumors-2024-04-05/
Pharmac inks deal with GlaxoSmithKline for new cancer, HIV and COPD drugs: About 30,000 New Zealanders with ovarian cancer, lung disease, HIV and other ...
rnz.co.nz/news/national/514103/pharmac-inks-deal-with-glaxosmithkline-for-new-cancer-hiv-and-copd-drugs
French pharmaceutical giant Sanofi has reached a tentative agreement to settle thousands of US lawsuits which link their heartburn pill Zantac to cancer www.reuters.com/legal/sanofi-settle-4000-zantac-cancer-lawsuits-us-state-courts-2024-04-03/
Denmark's Genmab to acquire ProfoundBio for $1.8 billion: Danish biotech Genmab has agreed to buy U.S. cancer drug maker ProfoundBio for $1.8 billion ...
reuters.com/markets/deals/denmarks-genmab-acquire-profoundbio-18-billion-2024-04-03/
Biocon leads India push into weight loss drugs as patents lapse: The Bengaluru-based firm is pivoting to anti-obesity therapies as patents for the blockbuster ...
dailymaverick.co.za/article/2024-04-08-biocon-leads-india-push-into-weight-loss-drugs-as-patents-lapse/
Changing 23andMe’s corporate DNA will be difficult: The company aims to exploit its extraordinary cache of genetic data for drug discovery
ft.com/content/b6b5c33f-1eb5-446e-9024-bd11d12a9cb0
The Dow drops 300 points as investors get jittery about inflation: Economists expect the consumer price index to increase from February
qz.com/dow-jones-industrial-average-inflation-fed-interest-rat-1851397283
The Dow struggles to recover as investors anxiously await inflation data — and the Fed
qz.com/dow-jones-inflation-report-consumer-price-index-1851398195
Gary Shteyngart: Crying Myself to Sleep on the Icon of the Seas: Seven agonizing nights aboard the Icon of the Seas
theatlantic.com/magazine/archive/2024/05/royal-caribbean-cruise-ship-icon-of-seas/677838/
A vaccine against cancer?: The well-known major manufacturers of mRNA vaccines are currently working on vaccinations against cancer.
spektrum.de/video/was-du-ueber-die-neue-impfung-gegen-krebs-wissen-musst/2212651
The top companies for training workers to use AI — including Amazon and GM: A new report reveals which firms are doing the most to advance AI literacy both ...
qz.com/amazon-gm-jpmorgan-moderna-ai-workforce-training-1851411624
Is any CEO worth the £18.7m AstraZeneca wants to pay boss Pascal Soriot?: Pascal Soriot was already the highest-paid leader of a FTSE 100 company ...
independent.co.uk/independentpremium/business/astrazeneca-salary-pascal-soriot-b2527111.html
Paid articlePaid
Without a brain implant: controlling computer games with your thoughts: Using EEG data and a pre-trained decoder, untrained test subjects were able to achieve a ...
heise.de/news/Gehirn-Schnittstelle-passt-sich-an-User-an-9676350.html
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
qz.com/novavax-covid19-mrna-1851410267
Quick Glance: Criticism of Novavax for Missed Opportunities in Boosting COVID-19 Vaccine Sales
- Shah Capital called for immediate changes in the company's board.
- The activist hedge fund Shah Capital criticized Novavax's leadership for not capitalizing on concerns some individuals have about mRNA vaccines to increase sales of its traditional, protein-based COVID-19 vaccine.
- Findings from a survey of 1,500 Americans by the Annenberg Public Policy Center (APPC) at the University of Pennsylvania revealed an increase in the spread of vaccine misinformation.
- The limited use of COVID-19 vaccines is also affecting other vaccine manufacturers. In the U.S., only 14% of adults have received an updated COVID-19 vaccine for 2023-2024, according to the Centers for Disease Control and Prevention.
Brain-Computer Interface Breakthrough Lets You Play Games With Your Mind: The new study differs from Musk-backed Neuralink’s BCI in a couple of ways ...
hothardware.com/news/brain-control-interface-breakthrough
Boehringer to lay off salespeople as Humira biosimilar sales lag: Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor U.S ...
reuters.com/business/healthcare-pharmaceuticals/boehringer-lay-off-salespeople-humira-biosimilar-sales-lag-2024-04-04/
Synchron Begins Planning Brain Chip Human Trials: The company hopes to attract dozens of volunteers for testing as it seeks FDA approval.
extremetech.com/science/synchron-begins-planning-brain-chip-human-trials
23andMe’s Fall From $6 Billion to Nearly $0: From celebrity “spit parties” to a drop in the bucket: The once-hot DNA-testing company is struggling to profit.
wsj.com/health/healthcare/23andme-anne-wojcicki-healthcare-stock-913468f4
A new drug to prevent migraines will soon become available on the NHS 🙌www.lancs.live/news/uk-world-news/migraine-breakthrough-new-pill-offered-28982114
Tesla is losing top executives as it lays off thousands of workers: More than 10% of the electric vehicle company's global workforce will lose their jobs ...
qz.com/tesla-elon-musk-mayoffs-executives-baglino-patel-1851410408
Quick Glance: Tesla: Layoffs and Elon Musk's Reality Check
- Tesla is planning a major layoff to prepare for the future.
- Elon Musk's grasp on reality is questioned as Tesla performs mediocre in the automotive industry.
- Tesla experiences a decline in revenue margin compared to other automakers.
- The success of Tesla's future depends on the implementation of autonomous driving technology.
US FDA warns of harmful reactions to fake Botox injections: The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-harmful-reactions-fake-botox-injections-2024-04-16/
Abbvie: New building strengthens research in Ludwigshafen: Abbvie: New building strengthens research in Ludwigshafen - major project - THE RHEINPALAZZ
rheinpfalz.de/lokal/pfalz-ticker_artikel,-abbvie-neubau-st%C3%A4rkt-forschung-in-ludwigshafen-_arid,5637367.html
In Bridgerton and Flonase Collaboration, Both Love and Allergies Are in Bloom: Shonaland proposed the collaboration ahead of Bridgerton's Season 3 premiere.
adweek.com/creativity/bridgerton-flonase-collaboration-shondaland/
Gain a better understanding of the technology shaping the future of the health and biotech industry when you sign up for our free weekly newsletter ... Show more
Shop Titans launches update 16.0 with new items, a fresh Elysium dungeon battle to take on and more
pocketgamer.com/shop-titans/update-16/
ICYMI! Watch the Splash with MASH replay to learn which patients are most at risk for metabolic dysfunction-associated steatohepatitis, or MASH ... Show more www.medscape.org/viewarticle/1000589
Nicole Shanahan, RFK Jr.’s Running Mate, Sets New Low for Anti-Vax Misinformation
thedailybeast.com/nicole-shanahan-rfk-jrs-running-mate-sets-new-low-for-anti-vax-misinformation
Paid articlePaid
Philly area biotech is worried about Congress’ crackdown on Chinese manufacturers
inquirer.com/business/philadelphia-biotech-congress-china-manufacturing-gene-cell-therapy-20240416.html
2 Cheap Growth Stocks to Buy During 2Q: These undervalued stocks from the growth side of the Morningstar Style Box are among our analysts’ favorites today.
morningstar.com/stocks/2-cheap-growth-stocks-buy-during-2q-2
Were COVID-19 Vaccines to Blame for Infertility? Heart Attacks? A New Report Weighs In
usnews.com/news/health-news/articles/2024-04-16/were-covid-19-vaccines-to-blame-for-infertility-heart-attacks-a-new-report-weighs-in
Humira biosimilar scripts take off: It marked one of the first major efforts to push biosimilar adoption.
axios.com/2024/04/16/humira-biosimilar-prescribing-surge
Serum Institute, Univercells tie-up for affordable personalised cancer care: SII was the world’s largest vaccine manufacturer with a global footprint of any ...
financialexpress.com/healthcare/news-healthcare/serum-institute-univercells-tie-up-for-affordable-personalised-cancer-care/3456066/
Bullish signal for biotech shares: Will this solve one of Novo Nordisk's biggest problems?
boerse-online.de/nachrichten/aktien/bullisches-signal-fuer-biotech-aktie-loest-das-eines-der-groessten-probleme-von-novo-nordisk-20355342.html
Genmab Acquires A Missing Piece For Its Pipeline: Genmab's acquisition of ProfoundBio for $1.8 billion in cash adds an important ADC platform ...
seekingalpha.com/article/4684021-genmab-acquires-a-missing-piece-for-its-pipeline
Paid articlePaid
Greifswalder AstraZeneca hero Greinacher receives award: During the Covid pandemic, his name was on everyone's lips - because Prof. Andreas Greinacher and his ...
ostsee-zeitung.de/lokales/vorpommern-greifswald/greifswald/greifswalder-astrazeneca-held-greinacher-wird-ausgezeichnet-WMG24FDT4ZBYHOZ5AURIBZPDN4.html
The concept of CEO-as-a-Service has the potential to revolutionize how the biotech industry addresses its development and commercialization hurdles, says ... Show more sbr.com.sg/videos/ceo-service-boosts-biotech-startups
AbbVie: Great To Be Proven Wrong - Still Not A Buy: AbbVie outperformed expectations, with Humira remaining the market leader with 98% share despite LOE and ...
seekingalpha.com/article/4683574-abbvie-great-to-be-proven-wrong-still-not-a-buy
Paid articlePaid
Vertex Pharma scientist talks about the long road to developing non-addictive painkillers
apnews.com/article/vertex-pharmaceuticals-pain-drug-opioid-medication-study-5ec38713f486ccbab827b7dd04aa8484
There's still plenty of shares to like on the poor old FTSE 100: City Voices: Taken together, London’s top flight mightn’t look so appealing ...
standard.co.uk/business/shares-ftse-100-london-stock-exchange-stocks-relx-astrazeneca-experian-b1151620.html
Thermo Fisher Scientific: Too Hot To Handle: Thermo Fisher Scientific's stock tends to be volatile and its organic revenue growth is stagnant ...
seekingalpha.com/article/4683821-thermo-fisher-scientific-too-hot-to-handle
Paid articlePaid
Are you ready to PERISH?: Having previously taken PC players on a journey into the unknown, it's now time for PlayStation and Xbox gamers to get ready to ...
thexboxhub.com/are-you-ready-to-perish/
Organovo's fatty liver disease drug meets main goal in mid-stage study: Organovo Holdings said on Monday its experimental drug to treat a type of fatty liver ...
reuters.com/business/healthcare-pharmaceuticals/organovos-fatty-liver-disease-drug-meets-main-goal-mid-stage-study-2024-04-15/
Why you should get your rash checked to know if it’s shingles : If not diagnosed and treated right away, shingles can lead to serious complications
rappler.com/brandrap/why-get-rash-checked-shingles/
Pfizer wants the first FDA approval ever for an RSV vaccine for young adults: There is currently no approved RSV vaccine for adults 18-59 years old
qz.com/pfizer-rsv-younger-adults-18-59-fda-approval-1851397604
Proxy advisers inflict ‘serious harm’ to UK, says AstraZeneca chair : Michel Demaré in FT hits out at ISS and Glass Lewis for applying ‘double standards’ after ...
ft.com/content/838177cd-af87-4b86-ac47-ecfc45665020
AstraZeneca chair: UK business needs a level playing field to compete: Double standards over pay do serious harm to our competitiveness in the war for talent
ft.com/content/86524f70-b121-4432-9403-94cd1c26f266
AstraZeneca promises dividend increase ahead of key vote on chief’s pay: Pharma group proposes raising pay for Pascal Soriot up to £18.7mn
ft.com/content/5b88670f-1e29-45f5-b6d7-6c0157bcd427
Bio-Rad: A Lackluster Picks-And-Shovels Life Science Company With A Key Investment Kicker
seekingalpha.com/article/4683639-bio-rad-a-lackluster-picks-and-shovels-life-science-company-with-a-key-investment-kicker
Paid articlePaid Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
What Neuralink Is Missing: It turns out that connecting brains with computers is the easy part.
theatlantic.com/technology/archive/2024/04/neuralink-bci-implant/677996/
Biontech: “Moderna has a one to two year lead when it comes to cancer drugs”: Biontech is working on over twenty drugs against cancer. The doctor and fund ...
wiwo.de/unternehmen/industrie/biontech-das-wuerde-ein-neues-zeitalter-in-der-krebstherapie-einleiten/29750834.html
Quick Glance: Innovative Cancer Therapy: Biontech's Advancement
- Biontech is actively developing over twenty cancer medications with promising results.
- Current developments and potential market introductions of cancer treatments.
- Significance of Biontech's promising results against pancreatic cancer.
Elon Musk's attack, Jamie Dimon's warnings, AstraZeneca CEO's big pay: Leadership news roundup
qz.com/elon-musk-jamie-dimon-inflation-astrazeneca-ceo-pay-1851406684
State-of-the-Art Care in Amyotrophic Lateral Sclerosis: Improving Diagnostic Accuracy and Therapeutic Efficacy
medscape.org/viewarticle/999480
KUZYYY 🚨🚨🚨Andrei Kuzmenko registers the second hat trick of his career!
Hat Trick Challenge presented by AstraZeneca US
FILLLLLL 🎩 Filip Forsberg's three goals brings him to 46 on the season!
Hat Trick Challenge presented by AstraZeneca US
AIIMS launches study to test accuracy of HPV kits for cervical cancer screening: Once validated across samples, the test kit can be rolled out for early ...
indianexpress.com/article/health-wellness/aiims-stufy-hpv-vaccines-cervical-cancer-screening-9266465/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics